المؤلفون: Lama J; Weill Cornell Medical College, New York City, NY, USA., Winograd J; Weill Cornell Medical College, New York City, NY, USA., Codelia-Anjum A; Department of Urology, Northwell Health, Manhasset, NY, USA., Bhojani N; Department of Urology, University of Montreal, Montreal, Canada., Elterman D; Division of Urology, University of Toronto, Toronto, Canada., Zorn KC; Department of Urology, University of Montreal, Montreal, Canada.; BPHCanada Prostate Surgery Institute, Montreal, QC, Canada., Chughtai B; Department of Urology, Northwell Health, Manhasset, NY, USA. bchughtai@northwell.edu.

المصدر: Current urology reports [Curr Urol Rep] 2024 Sep 23; Vol. 26 (1), pp. 4. Date of Electronic Publication: 2024 Sep 23.

نوع المنشور: Journal Article; Review

بيانات الدورية: Publisher: Current Science Country of Publication: United States NLM ID: 100900943 Publication Model: Electronic Cited Medium: Internet ISSN: 1534-6285 (Electronic) Linking ISSN: 15272737 NLM ISO Abbreviation: Curr Urol Rep Subsets: MEDLINE

مواضيع طبية MeSH: Prostatic Hyperplasia*/surgery , Prostatic Hyperplasia*/economics , Artificial Intelligence* , Cost-Benefit Analysis* , Clinical Decision-Making*, Humans ; Male ; Treatment Outcome ; Cost-Effectiveness Analysis

المؤلفون: Zi H; Center for Evidence-Based and Translational Medicine, Zhongnan Hospital of Wuhan University, Wuhan, 430071, China.; Evidence-Based Medicine Center, Xiangyang No. 1 People's Hospital, Hubei University of Medicine, Xiangyang, 441000, Hubei, China., Liu MY; Center for Evidence-Based and Translational Medicine, Zhongnan Hospital of Wuhan University, Wuhan, 430071, China.; Department of Urology, Wuhan Clinical Research Center of Tumors of the Urinary System and Male Genital Organs, Hubei Key Laboratory of Urinary System Diseases, Zhongnan Hospital of Wuhan University, Wuhan, 430071, China., Luo LS; Center for Evidence-Based and Translational Medicine, Zhongnan Hospital of Wuhan University, Wuhan, 430071, China., Huang Q; Center for Evidence-Based and Translational Medicine, Zhongnan Hospital of Wuhan University, Wuhan, 430071, China., Luo PC; Department of Urology, Wuhan Clinical Research Center of Tumors of the Urinary System and Male Genital Organs, Hubei Key Laboratory of Urinary System Diseases, Zhongnan Hospital of Wuhan University, Wuhan, 430071, China.; Department of Urology, Wuhan Third Hospital, Tongren Hospital of Wuhan University, Wuhan, 430060, China., Luan HH; Department of Forensic Medicine, Zhongnan Hospital of Wuhan University, Wuhan, 430071, China., Huang J; Center for Evidence-Based and Translational Medicine, Zhongnan Hospital of Wuhan University, Wuhan, 430071, China., Wang DQ; Center for Evidence-Based and Translational Medicine, Zhongnan Hospital of Wuhan University, Wuhan, 430071, China.; Department of Urology, Wuhan Clinical Research Center of Tumors of the Urinary System and Male Genital Organs, Hubei Key Laboratory of Urinary System Diseases, Zhongnan Hospital of Wuhan University, Wuhan, 430071, China., Wang YB; Center for Evidence-Based and Translational Medicine, Zhongnan Hospital of Wuhan University, Wuhan, 430071, China., Zhang YY; Center for Evidence-Based and Translational Medicine, Zhongnan Hospital of Wuhan University, Wuhan, 430071, China., Yu RP; Center for Evidence-Based and Translational Medicine, Zhongnan Hospital of Wuhan University, Wuhan, 430071, China.; Department of Urology, Wuhan Clinical Research Center of Tumors of the Urinary System and Male Genital Organs, Hubei Key Laboratory of Urinary System Diseases, Zhongnan Hospital of Wuhan University, Wuhan, 430071, China., Li YT; School of Clinical Medicine, Hubei University of Arts and Science, Xiangyang, 441053, Hubei, China., Zheng H; Department of Urology, Wuhan Clinical Research Center of Tumors of the Urinary System and Male Genital Organs, Hubei Key Laboratory of Urinary System Diseases, Zhongnan Hospital of Wuhan University, Wuhan, 430071, China. zh-urology@whu.edu.cn., Liu TZ; Department of Urology, Wuhan Clinical Research Center of Tumors of the Urinary System and Male Genital Organs, Hubei Key Laboratory of Urinary System Diseases, Zhongnan Hospital of Wuhan University, Wuhan, 430071, China. liutongzu@163.com., Fan Y; Department of Urology, Institute of Urology, Peking University First Hospital, Peking University, The National Urological Cancer Center of China, Beijing, 100034, China. dantefanbmu@pku.edu.cn., Zeng XT; Center for Evidence-Based and Translational Medicine, Zhongnan Hospital of Wuhan University, Wuhan, 430071, China. zengxiantao1128@whu.edu.cn.; Department of Urology, Wuhan Clinical Research Center of Tumors of the Urinary System and Male Genital Organs, Hubei Key Laboratory of Urinary System Diseases, Zhongnan Hospital of Wuhan University, Wuhan, 430071, China. zengxiantao1128@whu.edu.cn.

المصدر: Military Medical Research [Mil Med Res] 2024 Sep 18; Vol. 11 (1), pp. 64. Date of Electronic Publication: 2024 Sep 18.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: BioMed Central Country of Publication: England NLM ID: 101643181 Publication Model: Electronic Cited Medium: Internet ISSN: 2054-9369 (Electronic) Linking ISSN: 20549369 NLM ISO Abbreviation: Mil Med Res Subsets: MEDLINE

مواضيع طبية MeSH: Prostatic Neoplasms*/epidemiology , Prostatic Hyperplasia*/epidemiology , Prostatic Hyperplasia*/complications , Global Burden of Disease* , Urinary Tract Infections*/epidemiology , Urinary Bladder Neoplasms*/epidemiology , Urinary Bladder Neoplasms*/mortality , Kidney Neoplasms*/epidemiology , Kidney Neoplasms*/mortality, Humans ; Male ; Aged ; Middle Aged ; Prevalence ; Female ; Incidence ; Urolithiasis/epidemiology ; Urolithiasis/complications ; Adult ; Disability-Adjusted Life Years/trends ; Aged, 80 and over ; Risk Factors

المؤلفون: Cheng C; School of Pharmacy, Shenyang Pharmaceutical University, Wenhua Road 103, Shenyang, Liaoning, China., Xu C; School of Pharmacy, Shenyang Pharmaceutical University, Wenhua Road 103, Shenyang, Liaoning, China., Zhou W; School of Pharmacy, Shenyang Pharmaceutical University, Wenhua Road 103, Shenyang, Liaoning, China., Xue L; School of Pharmacy, Shenyang Pharmaceutical University, Wenhua Road 103, Shenyang, Liaoning, China., Wang S; School of Pharmacy, Shenyang Pharmaceutical University, Wenhua Road 103, Shenyang, Liaoning, China., Zhai Q; School of Pharmacy, Shenyang Pharmaceutical University, Wenhua Road 103, Shenyang, Liaoning, China., Dai R; School of Pharmacy, Shenyang Pharmaceutical University, Wenhua Road 103, Shenyang, Liaoning, China. Electronic address: ronghuadai@sina.com.

المصدر: Journal of pharmaceutical and biomedical analysis [J Pharm Biomed Anal] 2024 Sep 15; Vol. 248, pp. 116264. Date of Electronic Publication: 2024 May 31.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Elsevier Science Country of Publication: England NLM ID: 8309336 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-264X (Electronic) Linking ISSN: 07317085 NLM ISO Abbreviation: J Pharm Biomed Anal Subsets: MEDLINE

مواضيع طبية MeSH: Prostatic Hyperplasia*/drug therapy , Prostatic Hyperplasia*/blood , Anemarrhena*/chemistry , Metabolomics*/methods , Network Pharmacology*/methods , Phellodendron*/chemistry , Drugs, Chinese Herbal*/pharmacology , Drugs, Chinese Herbal*/chemistry , Signal Transduction*/drug effects, Male ; Animals ; Chromatography, High Pressure Liquid/methods ; Proto-Oncogene Proteins c-akt/metabolism ; Rats ; Rats, Sprague-Dawley ; NF-kappa B/metabolism ; Phosphatidylinositol 3-Kinases/metabolism ; Plant Extracts/pharmacology

المؤلفون: Kumar YN; Center for Industrial and Medical Ultrasound, University of Washington, Seattle, 98105, USA. ynandaku@uw.edu., Singh Z; Department of Urology, University of Washington, Seattle, 98195, USA., Wang YN; Center for Industrial and Medical Ultrasound, University of Washington, Seattle, 98105, USA., Kanabolo D; Department of Urology, University of Washington, Seattle, 98195, USA., Chen L; Department of Urology, University of Washington, Seattle, 98195, USA., Bruce M; Center for Industrial and Medical Ultrasound, University of Washington, Seattle, 98105, USA., Vlaisavljevich E; Department of Biomedical Engineering and Mechanics, Virginia Polytechnic Institute and State University, Blacksburg, 24061, USA., True L; Department of Pathology, University of Washington, Seattle, 98195, USA., Maxwell AD; Center for Industrial and Medical Ultrasound, University of Washington, Seattle, 98105, USA.; Department of Urology, University of Washington, Seattle, 98195, USA., Schade GR; Department of Urology, University of Washington, Seattle, 98195, USA.

المصدر: Scientific reports [Sci Rep] 2024 Sep 02; Vol. 14 (1), pp. 20365. Date of Electronic Publication: 2024 Sep 02.

نوع المنشور: Journal Article; Comparative Study

بيانات الدورية: Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN: 2045-2322 (Electronic) Linking ISSN: 20452322 NLM ISO Abbreviation: Sci Rep Subsets: MEDLINE

مواضيع طبية MeSH: Prostatic Hyperplasia*/therapy , Prostatic Hyperplasia*/pathology, Humans ; Male ; High-Intensity Focused Ultrasound Ablation/methods ; Elasticity Imaging Techniques/methods ; Fibrosis ; Prostate/pathology ; Prostate/diagnostic imaging

المؤلفون: Kristensen-Alvarez A; Department of Urology, Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark. anna.kristensen-alvarez@regionh.dk.; Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark. anna.kristensen-alvarez@regionh.dk., Fode M; Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark.; Department of Urology, Copenhagen University Hospital - Herlev and Gentofte, Herlev, Denmark., Stroomberg HV; Department of Urology, Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark.; Department of Public Health, University of Copenhagen, Copenhagen, Denmark., Nielsen KK; Department of Urology, Copenhagen University Hospital - Herlev and Gentofte, Herlev, Denmark., Arch A; Department of Urology, Copenhagen University Hospital - Herlev and Gentofte, Herlev, Denmark., Lönn LB; Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark.; Department of Radiology, Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark., Taudorf M; Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark.; Department of Radiology, Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark., Widecrantz SJ; Department of Urology, Zealand University Hospital, Roskilde, Denmark., Røder A; Department of Urology, Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark.; Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark.

المصدر: Trials [Trials] 2024 Sep 02; Vol. 25 (1), pp. 574. Date of Electronic Publication: 2024 Sep 02.

نوع المنشور: Journal Article; Clinical Trial Protocol; Comparative Study

بيانات الدورية: Publisher: BioMed Central Country of Publication: England NLM ID: 101263253 Publication Model: Electronic Cited Medium: Internet ISSN: 1745-6215 (Electronic) Linking ISSN: 17456215 NLM ISO Abbreviation: Trials Subsets: MEDLINE

مواضيع طبية MeSH: Prostatic Hyperplasia*/complications , Prostatic Hyperplasia*/therapy , Embolization, Therapeutic*/methods , Embolization, Therapeutic*/adverse effects , Lower Urinary Tract Symptoms*/etiology , Lower Urinary Tract Symptoms*/therapy , Lower Urinary Tract Symptoms*/diagnosis , Equivalence Trials as Topic* , Prostate*/blood supply, Humans ; Male ; Treatment Outcome ; Time Factors ; Microwaves/therapeutic use ; Microwaves/adverse effects ; Transurethral Resection of Prostate ; Severity of Illness Index ; Hyperthermia, Induced/methods ; Quality of Life ; Randomized Controlled Trials as Topic ; Multicenter Studies as Topic ; Aged

المؤلفون: Doersch KM; University of Rochester Medical Center, Rochester, New York, USA., Hines L; University of Rochester Medical Center, Rochester, New York, USA., Campbell TD; University of Rochester Medical Center, Rochester, New York, USA., Jain RK; University of Rochester Medical Center, Rochester, New York, USA., Quarrier SO; University of Rochester Medical Center, Rochester, New York, USA.

المصدر: Lower urinary tract symptoms [Low Urin Tract Symptoms] 2024 Sep; Vol. 16 (5), pp. e12533.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Richmond, Vic. Country of Publication: Australia NLM ID: 101506777 Publication Model: Print Cited Medium: Internet ISSN: 1757-5672 (Electronic) Linking ISSN: 17575664 NLM ISO Abbreviation: Low Urin Tract Symptoms Subsets: MEDLINE

مواضيع طبية MeSH: Lasers, Solid-State*/therapeutic use , Lasers, Solid-State*/adverse effects , Urinary Incontinence*/etiology , Prostatic Hyperplasia*/surgery , Prostatic Hyperplasia*/complications , Postoperative Complications*/etiology , Prostatectomy*/adverse effects , Prostatectomy*/methods, Humans ; Male ; Aged ; Middle Aged ; Aged, 80 and over ; Age Factors ; Laser Therapy/adverse effects ; Laser Therapy/methods ; Recovery of Function

المؤلفون: Lin T; Urology Nursing Unit of Nursing Department, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China., Zhong L; Urology Nursing Unit of Nursing Department, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.

المصدر: Psychogeriatrics : the official journal of the Japanese Psychogeriatric Society [Psychogeriatrics] 2024 Sep; Vol. 24 (5), pp. 1139-1148. Date of Electronic Publication: 2024 Aug 08.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Blackwell Pub Country of Publication: England NLM ID: 101230058 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1479-8301 (Electronic) Linking ISSN: 13463500 NLM ISO Abbreviation: Psychogeriatrics Subsets: MEDLINE

مواضيع طبية MeSH: Prostatic Hyperplasia*/nursing , Prostatic Hyperplasia*/psychology , Prostatic Hyperplasia*/therapy, Humans ; Male ; Aged ; Retrospective Studies ; Middle Aged ; Anxiety/psychology ; Depression/psychology ; Quality of Life/psychology ; Aged, 80 and over ; Psychosocial Intervention/methods ; Psychiatric Nursing/methods ; Treatment Outcome

المؤلفون: Inamura S; Department of Urology, Faculty of Medical Sciences, University of Fukui, Eiheiji, Japan., Terada N; Department of Urology, Faculty of Medical Sciences, University of Fukui, Eiheiji, Japan.

المصدر: International journal of urology : official journal of the Japanese Urological Association [Int J Urol] 2024 Sep; Vol. 31 (9), pp. 968-974. Date of Electronic Publication: 2024 Jun 27.

نوع المنشور: Journal Article; Review

بيانات الدورية: Publisher: Blackwell Science Asia Country of Publication: Australia NLM ID: 9440237 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1442-2042 (Electronic) Linking ISSN: 09198172 NLM ISO Abbreviation: Int J Urol Subsets: MEDLINE

مواضيع طبية MeSH: Prostatic Hyperplasia*/physiopathology , Prostatic Hyperplasia*/complications , Prostatic Hyperplasia*/therapy, Humans ; Male ; Lower Urinary Tract Symptoms/etiology ; Lower Urinary Tract Symptoms/physiopathology ; Lower Urinary Tract Symptoms/drug therapy ; Lower Urinary Tract Symptoms/therapy ; Prostate/pathology ; Prostate/immunology ; Prostate/physiopathology ; Prostatitis/physiopathology ; Prostatitis/drug therapy ; Prostatitis/immunology ; Prostatitis/therapy ; Prostatitis/etiology ; Chronic Disease ; Phosphodiesterase 5 Inhibitors/therapeutic use ; Inflammation/physiopathology ; 5-alpha Reductase Inhibitors/therapeutic use ; Adrenergic alpha-1 Receptor Antagonists/therapeutic use

المؤلفون: Winograd J; Department of Urology, Weill Cornell Medicine, New York, NY, USA., Venishetty N; Paul L. Foster School of Medicine, Texas Tech Health Sciences Center, El Paso, TX, USA., Codelia-Anjum A; Department of Urology, Weill Cornell Medicine, New York, NY, USA., Bhojani N; Division of Urology, University of Montreal, Montreal, Québec, Canada., Elterman D; Division of Urology, University of Toronto, Toronto, Ontario, Canada., Zorn KC; Division of Urology, University of Montreal, Montreal, Québec, Canada., Te A; Department of Urology, Weill Cornell Medicine, New York, NY, USA., Chughtai B; Department of Urology, Weill Cornell Medicine, New York, NY, USA.

المصدر: Expert opinion on emerging drugs [Expert Opin Emerg Drugs] 2024 Sep; Vol. 29 (3), pp. 205-217. Date of Electronic Publication: 2024 Jun 14.

نوع المنشور: Journal Article; Review

بيانات الدورية: Publisher: Taylor & Francis Country of Publication: England NLM ID: 101135662 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1744-7623 (Electronic) Linking ISSN: 14728214 NLM ISO Abbreviation: Expert Opin Emerg Drugs Subsets: MEDLINE

مواضيع طبية MeSH: Prostatic Hyperplasia*/drug therapy , Prostatic Hyperplasia*/physiopathology , Lower Urinary Tract Symptoms*/drug therapy , Lower Urinary Tract Symptoms*/etiology , Lower Urinary Tract Symptoms*/physiopathology , Drug Development* , 5-alpha Reductase Inhibitors*/therapeutic use , 5-alpha Reductase Inhibitors*/pharmacology , 5-alpha Reductase Inhibitors*/administration & dosage, Humans ; Male ; Animals ; Phosphodiesterase 5 Inhibitors/pharmacology ; Phosphodiesterase 5 Inhibitors/therapeutic use ; Adrenergic alpha-Antagonists/therapeutic use ; Adrenergic alpha-Antagonists/pharmacology ; Drug Design ; Middle Aged

المؤلفون: Zhan M; Department of Urology, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200011, China; Department of Systems Biology, Beckman Research Institute, City of Hope, Monrovia, CA, 91016, USA., Xu H; Department of Urology, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200011, China., Yu G; Department of Urology, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200011, China., Chen Q; Department of Urology, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200011, China., Yang R; Department of Urology, Fudan University Shanghai Cancer Center, Shanghai, 200032, China., Chen Y; Department of Urology, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200011, China., Ge J; Department of Urology, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200011, China., Wang Z; Department of Urology, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200011, China; Department of Urology, Shanghai Pudong New Area Gongli Hospital, Shanghai, 200135, China. Electronic address: zhongwang2000@sina.com., Yang R; Department of Pathology, City of Hope, Duarte, CA, 91010, USA; Department of Molecular Diagnostics & Endocrinology, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200011, China. Electronic address: ruyang@coh.org., Xu B; Department of Urology, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200011, China. Electronic address: chxb2004@shsmu.edu.cn.

المصدر: Redox biology [Redox Biol] 2024 Sep; Vol. 75, pp. 103298. Date of Electronic Publication: 2024 Aug 02.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Elsevier, B.V Country of Publication: Netherlands NLM ID: 101605639 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2213-2317 (Electronic) Linking ISSN: 22132317 NLM ISO Abbreviation: Redox Biol Subsets: MEDLINE

مواضيع طبية MeSH: Ferroptosis*/genetics , Prostatic Hyperplasia*/metabolism , Prostatic Hyperplasia*/genetics , Prostatic Hyperplasia*/pathology , Receptors, Androgen*/metabolism , Receptors, Androgen*/genetics , MicroRNAs*/genetics , Signal Transduction* , RNA, Long Noncoding*/genetics , Phospholipid Hydroperoxide Glutathione Peroxidase*/metabolism , Phospholipid Hydroperoxide Glutathione Peroxidase*/genetics, Male ; Humans ; Animals ; Mice ; Disease Susceptibility